Oxidative Medicine and Cellular Longevity / 2015 / Article / Fig 4

Research Article

Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment

Figure 4

CVB-D inhibits cytochrome c release from mitochondria into cytosol in the heart. (a) Representative blots of cytochrome c in cardiac mitochondrial and cytosolic fractions. (b) Quantitative analysis of cytochrome c protein expression. versus the control group; versus the DOX group.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.